3 Top Healthcare Stocks to Buy in October
Novo Nordisk could get its momentum back with its oral Wegovy pill. Danaher is a proven market-beater trading…
Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
Trump’s $150 Ozempic? Oz cautions it’s not a done deal, but patients and doctors say it could be a gamechanger
Janet McCaskill was on vacation in Arizona with her husband and best friend when she heard that President…
50 European corporates backing startups on the path to growth, innovation, and global impact
Across Europe, big companies are becoming strong backers of startup innovation, and corporate venturing is widely used as…
Fat-loss drug Mounjaro now India’s No. 2 pharma brand | India News
NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma…
Exclusive-Novo Nordisk cuts hit production line jobs at key US plant, posts show
By Maggie Fick and Soren Jeppesen LONDON/COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk has laid off dozens of employees at…
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors say
By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
Novo plans online launch for obesity pill once approved, Bloomberg News reports
(Reuters) -Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms…
Ozempic maker urges Ottawa to shut down online drug sales to Americans
OTTAWA — Novo Nordisk, the Danish drug company that makes Ozempic and Wegovy, wants the Canadian government to…
1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy Today
Novo Nordisk is leading the race to get an oral weight loss GLP-1 drug approved. It needs to…
GLP-1 Weight-Loss Pills Could Transform Treatment
A new era of weight-loss treatment could soon trade needles for pills. Drugmakers behind GLP-1 injections like Wegovy…